CLINICAL_TRIALS ClinicalTrials.gov record update

Post Marketing Surveillance to Monitor the Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus Vaccine, Rotarix™ When Administered According to the Prescribing Information to Indian Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00938327
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:42.943124+00:00
Published At: 2011-03-16T00:00:00+00:00
Record Updated At: 2018-01-02
Results Posted At: 2011-03-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Rotavirus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-01-02"
protocolSection.identificationModule.nctId: "NCT00938327"
protocolSection.identificationModule.officialTitle: "Post Marketing Surveillance to Monitor the Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals\u0027 Oral Live Attenuated Human Rotavirus Vaccine, Rotarix\u2122 When Administered According to the Prescribing Information to Indian Infants"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2011-03-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.